Raymond James Financial Services Advisors, Inc. Profound Medical Corp. Transaction History

Raymond James Financial Services Advisors, Inc.

$73.5 Billion
Q3 2024

A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Profound Medical Corp. stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 760,457 shares of PROF stock, worth $5.72 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

760,457

Previous 681,562 11.58%

Holding current value

$5.72 Million

Previous $5.72 Million 5.86%

% of portfolio

0.01%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	BUY	$7.47 - $11.18 $589,345 - $882,046	78,895 Added 11.58%	760,457 $6.05 Million
Q2 2024 Jul 19, 2024	BUY	$7.25 - $9.07 $406,703 - $508,799	56,097 Added 8.97%	681,562 $5.72 Million
Q1 2024 Apr 22, 2024	BUY	$7.3 - $9.46 $21,264 - $27,556	2,913 Added 0.47%	625,465 $5.34 Million
Q4 2023 Jan 16, 2024	BUY	$7.85 - $11.18 $563,983 - $803,227	71,845 Added 13.05%	622,552 $5.29 Million
Q3 2023 Oct 24, 2023	SELL	$7.91 - $13.27 $241,484 - $405,119	-30,529 Reduced 5.25%	550,707 $5.62 Million
Q2 2023 Jul 25, 2023	BUY	$9.27 - $14.88 $635,300 - $1.02 Million	68,533 Added 13.37%	581,236 $7.56 Million
Q1 2023 Apr 14, 2023	BUY	$8.85 - $13.27 $1.72 Million - $2.59 Million	194,893 Added 61.32%	512,703 $4.76 Million
Q4 2022 Feb 08, 2023	BUY	$3.18 - $10.91 $893,045 - $3.06 Million	280,832 Added 759.46%	317,810 $3.46 Million
Q3 2022 Oct 25, 2022	SELL	$3.99 - $9.3 $1,065 - $2,483	-267 Reduced 0.72%	36,978 $149,000
Q2 2022 Aug 12, 2022	SELL	$6.34 - $9.53 $61,282 - $92,116	-9,666 Reduced 20.6%	37,245 $272,000
Q1 2022 May 11, 2022	BUY	$8.16 - $11.33 $67,581 - $93,835	8,282 Added 21.44%	46,911 $422,000
Q4 2021 Feb 08, 2022	SELL	$10.38 - $15.2 $348,622 - $510,507	-33,586 Reduced 46.51%	38,629 $436,000
Q3 2021 Nov 02, 2021	BUY	$13.6 - $17.88 $163,920 - $215,507	12,053 Added 20.03%	72,215 $1.05 Million
Q2 2021 Aug 11, 2021	SELL	$16.0 - $20.59 $3,104 - $3,994	-194 Reduced 0.32%	60,162 $980,000
Q1 2021 May 14, 2021	BUY	$19.16 - $28.09 $65,144 - $95,506	3,400 Added 5.97%	60,356 $1.21 Million
Q4 2020 Feb 12, 2021	BUY	$16.4 - $22.9 $233,831 - $326,508	14,258 Added 33.39%	56,956 $1.17 Million
Q3 2020 Nov 04, 2020	BUY	$14.05 - $18.13 $440,678 - $568,647	31,365 Added 276.76%	42,698 $751,000
Q2 2020 Jul 17, 2020	SELL	$9.41 - $16.94 $37,856 - $68,149	-4,023 Reduced 26.2%	11,333 $192,000
Q1 2020 Apr 21, 2020	BUY	$6.88 - $19.7 $105,649 - $302,513	15,356 New	15,356 $148,000

Others Institutions Holding PROF

# of Institutions

Shares Held

8.93M

Call Options Held

1.2K

Put Options Held

View Full List

About Profound Medical Corp.

Ticker PROF
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 20,851,300
Market Cap $157M
Description
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for...

More about PROF

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Account

Raymond James Financial Services Advisors, Inc. Profound Medical Corp. Transaction History